THANK YOU FOR SUBSCRIBING
Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
According to a recently published Fact.MR report, the global Neurointerventional Devices market is projected to grow at a compound annual rate of 8 percent between 2021 and 2031.
FREMONT, CA: Healthcare has changed dramatically in recent times, owing to rising disease prevalence, technological advancements, and increased overall healthcare spending. In the last decade, there has been an increase in neurological illnesses. The increased occurrence of brain aneurysms is propelling the Neurointerventional devices sector. The global Neurointerventional Devices market is expected to increase at a compound annual rate of 8 percent between 2022 and 2031. By the end of 2031, the market is estimated to be worth USD 5 billion. Over the projection period, demand for Neurointerventional Devices increased, with a market valued at USD 2.3 billion in 2020.
Over the next few years, the growing senior population is likely to have a significant impact on the need for Neurointerventional devices. Neurointerventional device adoption is now limited to developed regions such as North America and Europe, which are expected to be very profitable markets over the projected period. However, as time passes, the popularity and use of Neurointerventional devices are expected to rise throughout APAC and Latin America.
As more neurological illnesses are addressed, the use of Neurointerventional devices has increased dramatically in recent years. Minimally invasive technologies and procedures have achieved widespread acceptance and appeal among neurosurgeons and patients alike. This is because minimally invasive techniques result in faster healing and reduced discomfort. Manufacturers are researching and developing technologically improved Neurointerventional devices to provide effective treatments and maximize their income potential. Neurosurgeons' increasing demand for Neurointerventional devices is likely to play a key role in the development of more precise and effective devices.
This market analysis profiles some of the leading manufacturers of Neurointerventional devices, including Boston Scientific Corporation, Medtronic plc, St. Jude Medical, Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Inc., and Saluda Medical Pty Ltd.
Read Also
